Koninklijke Philips N.V.

PHG Healthcare Medical Devices

Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024. In the quarter to June 2026, revenue grew 2.94%, EPS grew 56.7%, free cash flow grew 49.7% and total debt fell 9.93%, each against the same quarter a year earlier.

25.74 0.25 +0.98%
Market cap
$24.9B
P/E
18.8×
Fwd P/E
11.2×
Dividend yield
3.94%
F-score
7/9
Altman Z
1.98
Beneish M
−2.68
Dividend safety
55/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
19.86 22.85 24.87 33.65

+8 more quarters

P/S ratio
1.26 1.28 1.27 1.36
P/FCF ratio
14.05 14.78 44.24 0.00
P/Operating CF
59.63 118.50 16.23 71.24
P/B ratio
1.95 1.95 2.07 2.10
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
1.51 1.52 1.50 1.68
EV/EBITDA
9.19 10.26 10.50 11.16
EV/Operating CF
11.98 12.26 22.83 (93.09)
EV/FCF
16.85 17.59 52.15 (25.95)
Quick Ratio
0.73 0.80 0.86 0.76
Current Ratio
1.26 1.32 1.32 1.32
Net Debt/EBITDA
4.51 8.34 5.15 8.10
Debt/Assets
23.65% 25.27% 25.73% 27.48%
Debt/Equity
0.55 0.60 0.63 0.68
Asset Turnover
0.67 0.68 0.65 0.61
Operating CF/Net income
0.98 1.25 3.55 1.69
Capex/Depreciation
(0.40) (0.60) (0.70) (0.51)
Interest Coverage
6.42 2.90 4.94 4.22
Research and Development Expense of Revenue
11.10% 10.09% 8.49% 9.62%
Selling, General and Administrative Expense of Revenue
27.68% 30.32% 25.81% 27.38%
Intangible Assets out of Total Assets
0.46 0.45 0.44 0.45
Share Based Compensation of Revenue
1.17% 0.77% 0.50% 0.80%
Graham Net Nets
(0.26) (0.27) (0.27) (0.29)
Graham Number
20.74 19.46 17.92 15.40
Earnings Yield
5.03% 4.38% 4.02% 2.97%
Free Cash Flow Yield
7.12% 6.76% 2.26% (4.76%)
Revenue per Share
5.31 4.80 6.23 5.29
Operating CF per Share
0.46 0.23 1.67 0.38
Capex per Share
(0.18) (0.20) (0.21) (0.20)
Free Cash Flow per Share
0.27 0.03 1.46 0.18
Cash per Share
2.25 3.28 3.43 2.45
Shareholders Equity per Share
13.96 14.04 13.11 13.01
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
13.96 14.04 13.11 13.01
Free Cash Flow
259.07 32.77 1,384.61 173.20
Working Capital
2,218.43 2,753.95 2,741.38 2,627.68
Capital Expenditures
(176.66) (187.26) (197.38) (190.63)
Net Current Asset Value
(6,854.12) (7,097.31) (6,813.30) (7,573.31)
EV/EBIT
15.71 17.93 18.79 23.31
Capex to Sales
0.03 0.04 0.03 0.04
Price to Operating Income
13.10 15.07 15.94 18.85
Other line items
Average Receivables
3,979.52 3,766.77 4,150.20 4,048.70
Average Payables
3,010.77 2,128.50 2,086.24 1,898.56
Average Inventory
3,704.10 3,574.58 3,568.44 4,137.90
Average Assets
30,495.35 30,266.28 31,112.50 31,480.50
Average Common Equity
12,580.31 12,858.43 12,633.70 12,815.45

Fold the line items

Columns are period end dates